Rahoto kan sakamakon kudi na kamfanin Aimmune Therapeutics, Inc., Aimmune Therapeutics, Inc. shekara-shekara na samun kudin shiga ga shekara ta 2024. Yaushe Aimmune Therapeutics, Inc. buga rahotanni na kudi?
Aimmune Therapeutics, Inc. jimlar kudaden shiga, ribar shiga gida da kuma sauye-sauye na canje-canje a US dollar a yau
Aimmune Therapeutics, Inc. kudin shiga na yanzu a US dollar. Canjin Aimmune Therapeutics, Inc. kudaden shiga da ya samu ta hanyar 0 $ a tsawon bara. Thearfafawar Aimmune Therapeutics, Inc. samun kuɗin shiga ƙasa ya ragu ta hanyar -1 577 000 $ na lokacin rahoton da ya gabata. Aimmune Therapeutics, Inc. ginshiƙi akan rahoton hada-hadar kudi ta yanar gizo. Shafin rahoton hada-hadar kudade a shafin yanar gizonmu yana nuna bayanan ta hanyar kwanakin da 30/06/2017 to 30/09/2019. Aimmune Therapeutics, Inc. jimlar kudaden shiga akan zane an nuna shi da rawaya.
Rahoton Rahoton
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
kuma
Canji (%)
Daidaita rahoton da aka kai a shekara ta wannan shekara tare da rahoto na shekara ta bara.
30/09/2019
0 $
-
-64 455 000 $
-
30/06/2019
0 $
-
-62 878 000 $
-
31/03/2019
0 $
-
-54 266 000 $
-
31/12/2018
0 $
-
-56 998 000 $
-
30/09/2018
0 $
-
-51 702 000 $
-
30/06/2018
0 $
-
-52 552 000 $
-
31/03/2018
0 $
-
-49 500 000 $
-
31/12/2017
0 $
-
-41 166 000 $
-
30/09/2017
0 $
-
-31 792 000 $
-
30/06/2017
0 $
-
-32 497 000 $
-
Nuna:
To
Rahoton kudi Aimmune Therapeutics, Inc., tsarawa
Zamanin sabbin bayanan kudi na Aimmune Therapeutics, Inc.: 30/06/2017, 30/06/2019, 30/09/2019. Kwanan bayanan bayanan kuɗi ana kiyaye su ta hanyar doka da kuma bayanan kuɗi. Kwanan kwanan rahoton rahoton kuɗi na Aimmune Therapeutics, Inc. na yau shine 30/09/2019. Ribar kuɗi Aimmune Therapeutics, Inc. shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton. Ribar kuɗi Aimmune Therapeutics, Inc. ne -64 455 000 $
Dates na kudi rahotanni Aimmune Therapeutics, Inc.
Jimlar bashi Aimmune Therapeutics, Inc. shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda. Jimlar bashi Aimmune Therapeutics, Inc. ne 95 706 000 $ Cash flow Aimmune Therapeutics, Inc. is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar. Cash flow Aimmune Therapeutics, Inc. ne -50 850 000 $
30/09/2019
30/06/2019
31/03/2019
31/12/2018
30/09/2018
30/06/2018
31/03/2018
31/12/2017
30/09/2017
30/06/2017
Babban riba
Babban riba shine ribar da kamfani ke karɓa bayan da ya rage kudin da ake samarwa da sayar da kayansa da / ko kudin da zai samar da ayyukansa.
-
-
-
-
-
-
-
-
-
-
Farashin farashi
Kudin shi ne yawan kuɗin da aka samar da rarraba kayayyaki da ayyuka na kamfanin.
-
-
-
-
-
-
-
-
-
-
Jimlar kudade
An kiyasta yawan kudaden shiga ta hanyar ninka yawan kayan da aka sayar da farashin kaya.
-
-
-
-
-
-
-
-
-
-
Hanyoyin shiga
Hanyoyin sarrafa kuɗi sun karu daga asusun kasuwancin kamfanin. Alal misali, mai sayar da kaya yana haifar da samun kudin shiga ta hanyar sayar da kayayyaki, kuma likita ya karbi kuɗi daga sabis na kiwon lafiya wanda ya bayar.
-
-
-
-
-
-
-
-
-
-
Haɗin aiki
Sakamakon aiki yana da ma'auni na lissafin kudi wanda ke daidaita yawan ribar da aka samu daga ayyukan kasuwanci, bayan da ya rage kudaden aiki, kamar albashi, haɓakawa da kuma kaya na kaya da aka sayar.
-64 602 000 $
-63 188 000 $
-55 028 000 $
-58 433 000 $
-52 976 000 $
-53 813 000 $
-50 119 000 $
-41 640 000 $
-32 289 000 $
-33 004 000 $
Ribar kuɗi
Ribar kuɗi shine asusun kuɗi na ƙwarewar ya rage yawan kuɗin da aka sayar, farashi da haraji don lokacin yin rahoton.
-64 455 000 $
-62 878 000 $
-54 266 000 $
-56 998 000 $
-51 702 000 $
-52 552 000 $
-49 500 000 $
-41 166 000 $
-31 792 000 $
-32 497 000 $
R & D kudi
Binciken bincike da ci gaba - kudaden bincike don inganta samfurori da hanyoyin da ake samuwa ko kuma samar da sababbin samfurori da hanyoyin.
30 558 000 $
31 988 000 $
31 316 000 $
33 029 000 $
31 691 000 $
35 254 000 $
33 446 000 $
28 654 000 $
21 063 000 $
22 191 000 $
Ayyukan sarrafawa
Kayan aiki shine kudaden da kasuwancin ke haifarwa saboda sakamakon ayyukan kasuwanci na yau da kullum.
64 602 000 $
63 188 000 $
55 028 000 $
58 433 000 $
52 976 000 $
53 813 000 $
50 119 000 $
41 640 000 $
32 289 000 $
33 004 000 $
Abubuwan da ke yanzu
Abubuwan da ake amfani da su a yanzu shine takarda na ma'auni wanda ya wakilta dukiyar dukiyar da za'a iya juyo cikin kuɗi a cikin shekara guda.
202 236 000 $
250 531 000 $
291 391 000 $
312 619 000 $
261 792 000 $
296 826 000 $
330 297 000 $
189 111 000 $
218 093 000 $
242 612 000 $
Total dukiya
Jimlar dukiyar kuɗi ce ta kuɗin kuɗin kuɗin kuɗin kuɗin kungiyar, bashin bashi, da dukiya na kayan aiki.
248 398 000 $
298 776 000 $
344 153 000 $
339 555 000 $
287 463 000 $
326 656 000 $
361 845 000 $
206 934 000 $
233 670 000 $
256 354 000 $
Kudi na yanzu
Kasuwanci na yanzu shine kudaden kuɗin da kamfanin ya gudanar a ranar rahoton.
76 844 000 $
72 564 000 $
81 058 000 $
107 511 000 $
78 420 000 $
142 157 000 $
209 324 000 $
73 487 000 $
73 821 000 $
84 451 000 $
Yanzu bashi
Dalili na yanzu shine ɓangare na bashin da za a biya a wannan shekara (watannin 12) kuma an nuna shi a matsayin wani alhaki na yanzu da kuma ɓangare na babban kamfanonin aiki.
43 605 000 $
43 211 000 $
38 091 000 $
38 012 000 $
-
-
-
-
-
-
Jimlar kuɗi
Jimlar kuɗin kuɗi ne adadin duk kuɗin da kamfanin yake da shi a cikin asusunsa, ciki har da ƙananan kuɗi da kudade da aka gudanar a banki.
-
-
-
-
255 249 000 $
290 000 000 $
321 884 000 $
182 430 000 $
212 030 000 $
237 325 000 $
Jimlar bashi
Jimlar bashi shine haɗuwa da gajeren lokaci da dogon lokaci. Lokaci bashi ne waɗanda dole ne a biya a cikin shekara guda. Lokaci na dogon lokaci ya hada da dukan wajibai waɗanda dole ne a biya su bayan shekara guda.
95 706 000 $
93 802 000 $
87 852 000 $
40 608 000 $
-
-
-
-
-
-
Yanayin bashi
Jimlar bashi ga duk dukiya shi ne haɗin kudi wanda ya nuna yawan yawan dukiyar da kamfanin ke wakilta a matsayin bashi.
38.53 %
31.40 %
25.53 %
11.96 %
-
-
-
-
-
-
Hakki
Adalci shine adadin dukan dukiya na mai shi bayan da ya cire duk wata albashi daga dukiyar kuɗi.
152 692 000 $
204 974 000 $
256 301 000 $
298 947 000 $
247 164 000 $
287 838 000 $
329 092 000 $
177 805 000 $
210 589 000 $
236 791 000 $
Cash flow
Cash flow is bashin tsabar kuɗi da tsabar kuɗin da ake ciki a cikin kungiyar.
-50 850 000 $
-46 166 000 $
-45 829 000 $
-51 550 000 $
-41 261 000 $
-36 553 000 $
-39 764 000 $
-31 927 000 $
-24 326 000 $
-20 248 000 $
Rahoton kudi na baya-bayan nan game da kudin shiga na Aimmune Therapeutics, Inc. shine ranar 30/09/2019. A cewar sabon rahoto game da sakamakon kudi na Aimmune Therapeutics, Inc., yawan kudaden da Aimmune Therapeutics, Inc. ya samu ya kai 0 US dollar kuma ya canza zuwa 0% idan aka kwatanta da shekara ta gaba. Sakamakon riba na Aimmune Therapeutics, Inc. a cikin kwata na karshe shine -64 455 000 $, karuwar riba ta karu da 0% idan aka kwatanta da bara.
Kudin hannun jari Aimmune Therapeutics, Inc.
Kudin hannun jari Aimmune Therapeutics, Inc.
Sharorin Aimmune Therapeutics, Inc. a yau, farashin kayayyaki AIMT yana da layi yanzu.
